MTSR - Metsera, Inc.
NEXT EARNINGS:
Mar 25, 2026
(in 28 days)
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$55.50
DETAILS
HIGH:
$57.00
LOW:
$54.00
MEDIAN:
$55.50
CONSENSUS:
$55.50
DOWNSIDE:
21.28%
Market Cap:
7.43B
Volume:
27,874,411
Avg Volume:
3,501,952
52 Week Range:
12.3-83.8599
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.70
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
93
IPO Date:
2025-01-31
EPS (TTM):
-2.03
P/E Ratio:
-13.06
Revenue (TTM):
N/A
Total Assets:
450.99M
Total Debt:
9.80M
Cash & Equiv:
352.45M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-56.9%
Debt/Equity:
0.03
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-12 | $-1.11 | $-0.56 | -98.2% | — | — | — |
| 2025-07-28 | $-0.66 | $-0.66 | -0.3% | — | — | — |
| 2025-05-12 | $-1.03 | $-0.85 | -21.2% | — | — | — |
| 2025-03-26 | $-3.52 | $-0.80 | -340.0% | — | — | — |
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Net Income | (209.13M) | (47.21M) | (813,000) |
| EPS | -2.03 | -0.95 | -0.02 |
| Total Assets | 450.99M | 168.84M | 14.98M |
| Total Debt | 9.80M | 0 | 15.18M |
| Cash & Equivalents | 352.45M | 75.19M | 14.98M |
| Operating Cash Flow | (99.79M) | (35.39M) | (537,000) |
| Free Cash Flow | (99.83M) | (35.42M) | (537,000) |
| FCF per Share | -0.97 | -0.71 | -0.01 |
| Book Value | 287.35M | 98.50M | (813,000) |
| Cash & ST Investments | 352.45M | 75.19M | 14.98M |
| ROC Equity | -0.73 | -0.48 | N/A |